Director of Machine Learning - Antibodies
About Us Alchemab has developed a highly differentiated platform that identifies novel drug targets and therapeutics through analysis of patient antibody repertoires. By combining well-defined patient samples, deep B cell sequencing, and computational analysis, the platform uncovers convergent protective antibody responses among individuals that are susceptible but resilient to specific...